LUCD News and Press, Lucid Diagnostics Inc.

Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 PR Newswire Conference Call and Webcast at 8:30 AM ET NEW YORK , March 12, 2026 /PRNewswire/ --  Lucid Diagnostics Inc.   (Nasdaq: LUCD)  ...

PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities PR Newswire Series D Preferred Stock offering yielded $30 million of gross proceeds and includes warrants exercisable for up to an additional $30 milli...

2026-01-26 10:10:05 ET ... Read the full article on Seeking Alpha For further details see: Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral

2026-01-21 08:47:16 ET More on Lucid Diagnostics, PAVmed PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript Lucid Diagnostics Inc. 2025 Q3 - Results - Earnings Call Presentation PAVmed Inc. 2025 Q3 - Results - Earnings Call Presentation P...

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® PR Newswire NEW YORK , Jan. 21, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagn...

PAVmed Announces Reverse Stock Split PR Newswire NEW YORK , Dec. 30, 2025 /PRNewswire/ --  PAVmed Inc.  (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital...

2025-12-10 10:15:04 ET Ascendiant analyst issues BUY recommendation for LUCD on December 10, 2025 03:12PM ET. The previous analyst recommendation was Buy. LUCD was trading at $1.125 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection PR Newswire Report includes nearly 12,000 patients who underwent Lucid's EsoGuard ® Esophageal DNA Test on samples collected using its EsoCheck ® ...

2025-12-08 05:21:52 ET More on Lucid Diagnostics Lucid Diagnostics Inc. 2025 Q3 - Results - Earnings Call Presentation Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript Lucid Diagnostics: Holding Onto Medicare Coverage Hopes Lucid Diagnostics sig...

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree PR Newswire Recognized as the leading company in its size category in program honoring the top workplaces across the diagnostics and precision-medicine sectors NEW YORK , Nov. 20, 2025 /PRNe...